Newton-Wellesley Hospital is a community teaching medical center located in Newton, Massachusetts on Washington Street. It is affiliated with Tufts University School of Medicine and Harvard Medical School.

There are 273 beds in Newton-Wellesley Hospital.

During the past decade, Newton-Wellesley Hospital conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 46 clinical trials were completed, i.e. on average, 102.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 21 clinical trials were completed. i.e. 123.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Newton-Wellesley Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "Massachusetts General Hospital" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Dana-Farber Cancer Institute" with 6 trials sponsored and "Boehringer Ingelheim" with 6 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newton-Wellesley Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "Newton-Wellesley Hospital" with 6 trials as a collaborator, "Brigham and Women's Hospital" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Newton-Wellesley Hospital" are "Breast Cancer" (11 trials), "Recurrent Breast Carcinoma" (6 trials), "COVID-19" (4 trials), "HER2/Neu Negative" (4 trials) and "Multiple Myeloma" (4 trials). Many other conditions were trialed in "Newton-Wellesley Hospital" in a lesser frequency.

Most popular intervention types in "Newton-Wellesley Hospital" are "Drug" (57 trials), "Other" (39 trials), "Biological" (14 trials), "Procedure" (10 trials) and "Behavioral" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Paclitaxel" (8 trials), "Placebo" (6 trials), "Quality-of-Life Assessment" (5 trials) and "placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Newton-Wellesley Hospital" are 74 trials for "All" genders, 21 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Newton-Wellesley Hospital". undefined are not yet recruiting, 12 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Newton-Wellesley Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Newton-Wellesley Hospital, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 21 trials that are defined as “Not Applicable".

Newton-Wellesley Hospital has several departments that took part in Clinical trials: "Newton Wellesley Urology" - 2 trials, "New England Hematology/Oncology Associates" - 2 trials